Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has announced updates from transactions in 2023 as part of the Company’s ongoing Portfolio Optimization Program. Fresenius Medical Care has now signed and closed transactions exiting its Argentina operations with the sale to Grupo Olmos. The Company also closed the sale of its National Cardiovascular Partners (NCP) outpatient cardiovascular clinics business in the United States in December 2023. Additionally, Fresenius Medical Care has signed the divestment of its Cura Day Hospitals Group in Australia (Cura) to global alternative asset manager ICG and a consortium of healthcare professionals, subject to regulatory approval. In aggregate, the three divested assets include 127 facilities, more than 4,500 employees and more than 10,000 dialysis patients.
Read the full article: Fresenius Medical Care Reports Divestitures, Including National Cardiovascular Partners //
Source: https://www.prnewswire.com/news-releases/fresenius-medical-care-executes-on-its-strategic-portfolio-optimization-program-and-announces-key-transactions-302028511.html